All-payer claims databases (APCDs) would benefit from mapping morbidity rates to the data resulting in pricing transparency, as well as pricing, efficiency and performance assessments that can be compared among providers. Mapping morbidity rates using publicly available data would create a clear idea of healthcare effectiveness and enrich the data, enabling patterns of care and value to emerge and in result, improve the future of healthcare. Here's a preview of Virginia Long and David Mould's piece on iHealthBeat that went live today:
All-payer claims databases (APCDs) that are in place in several states and about to be implemented in many more, are intended to make provider and hospital costs transparent. The readily available data within the APCDs includes claims data for medical, mental health, pharmacy, and dental procedures across providers. Access to this data enables analysis, analysis that can be done to make important comparisons such as price for services or performance measures at the level of physician or hospital—across a state. Thus, the APCDs can provide powerful and illuminating information, from tracking state healthcare spending to guiding patient/consumer choices.
Augmenting APCD data
Although APCDs can provide useful information on cost and value of healthcare within a state, augmenting the claims data with publically available morbidity data would provide users with a more holistic dataset where cost information is directly tied to clinical outcomes. Mapping disease morbidity information to APCDs would allow effectiveness of treatment to be assessed, alongside cost and quality measures. Treatment costs relative to disease burden within distinct locations can be used to pinpoint areas with health disparities, highlighting potential problems or incongruities in access to or quality of care.
Health and Morbidity Data
Publically available health data is available through many sources. A few of the major health related data sources are the Center for Disease Control and Prevention (CDC), the Community Health Status Indicators (CHSI), and the County Health Rankings. The CDC is not just concerned with communicable diseases; they are at the forefront of the fight against chronic diseases that adversely affect health in America. CDC data on disease are readily available and data maps for social determinants of health have the potential to bring together highly relevant and sometimes overlooked data. The CHSI provides information on health indicators such as tobacco use, diet and activity, alcohol and drug use, to create community profiles. Measures of health, causes of death, population vulnerability, and access to care, demographics, and risk factors are among the reports available on a county by county basis. The County Health Rankings & Roadmap program collects data about factors that influence health that includes high school graduation rates, obesity, unemployment, access to healthful foods, air and water quality. County Health Rankings provides information about health outcomes such as length of life and quality of life, as measured by poor health, poor mental health, and low birth weight.
Integration of public datasets with the APCDs
The addition of health factors and morbidity data would create a rich data set. Advanced analysis of the APCDs in conjunction with health and morbidity measurements will highlight interesting, important, or overlooked relationships among claims data, health outcomes, and factors influencing health. Through exploring and understanding these relationships, all stakeholders in the healthcare system will have a better understanding of how cost, quality, and effectiveness of care intersect. Literal mapping of these data, by using location based datasets, would enable users of all analytic levels to consume the data visually.
To read more about Virginia Long and David Mould’s thoughts on APCDs, visit the full iHealthBeat post, “Link All-Payer Claims Databases With Other Data To Boost Transparency.”
Get our take on industry trends
Three ways to improve patient retention in recovery programs
Deaths from drug overdoses have increased from ~1 per 100,000 in 1999 to ~4 per 100,000 in 2020.1 The introduction…
Read on...ACOs and value-based care in 2024: Four key questions and answers
ACOs have long been at the front lines of value-based care efforts. In a recent LinkedIn Fireside Chat, Andy Dé…
Read on...How is telehealth impacting STARs performance?
STAR scores are a critical component of success for Medicare Advantage Plans, MSSP and REACH ACOs, driving them to maximize…
Read on...Brief introduction to contract administration
At the top of the year, Rahul Sharma, Chief Executive Officer, and Lynn Carroll, Chief Operating Officer and Cofounder of…
Read on...